Impressive Q4 Growth for BeautyHealth with SkinStylus Expansion
The Beauty Health Company (NASDAQ: SKIN), the powerhouse behind the renowned brand Hydrafacial, unveiled their remarkable Q4 2025 financial results on March 12, 2026. The report highlighted a significant surge in the skin health market.
The company’s adjusted EBITDA for Q4 stood at $15 million, a substantial increase from the previous year’s $9 million. This marks a 67% year-over-year increase. The net loss for the quarter also saw improvement, decreasing to $8.1 million from Q4 2024’s $10.3 million.
BeautyHealth is broadening its reach in the skin health ecosystem through the escalating adoption of SkinStylus Nano-Channeling. This innovative approach is quickly becoming a favored complement to Hydrafacial treatments. The aim is to meet the growing consumer demand for combination treatments that boost performance and amplify results.
Looking Ahead: 2026 Projections
For the full year of 2026, BeautyHealth projects a revenue in the range of $285 million to $305 million. They also anticipate a positive adjusted EBITDA of $35 million to $45 million. The company is transitioning from a single-product focus to a comprehensive skin health platform. CEO Pedro Malha has stated that 2026 will be a pivotal year, with a focus on stabilization and investment into the next phase of growth.
Source: BeautyHealth News Releases